DARE DARE BIOSCIENCE INC Capital Structure Changes 8-K Filing 2024 - Stock Purchase Agreement DARE Bioscience, Inc. has entered into a purchase agreement with Lincoln Park Capital Fund to sell up to $15 million in shares of its common stock over the next 24 months, with certain conditions and limitations on the sales.Get access to all SEC 8-K filings of the DARE BIOSCIENCE INC